1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Biliary Tract Cancers: new trials by email Literature Review of Biliary Tract Cancers trials Research Report on Biliary Tract Cancers
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 3b, Open-label, Multi-center Study on Durvalumab in Combination With Gemcitabine-based Chemotherapy as 1L Treatment for the Chinese Patients With Unresectable Biliary Tract Cancers (BTC) durvalumab - Biliary Tract Cancers | Phase 3 | Completed | AstraZeneca | 116 | 2023-07-21 | 2025-04-22 |
Biliary Tract Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1)
durvalumab (1)
AstraZeneca (1)
China (1)